Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial

The Lancet Neurology

Volumn 19, Issue 8, 2020, Pages 661-669

  Lundström, Erik ^a   Isaksson, Eva ^a   Näsman, Per ^a   Wester, Per ^a   Mårtensson, Björn ^a   Norrving, Bo ^a   Wallén, Håkan ^a   Borg, Jörgen ^a   Dennis, Martin ^a   Mead, Gillian ^a   Hankey, Graeme J ^a   Hackett, Maree L ^a   Sunnerhagen, Katharina S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BIPOLAR DISORDER; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CENTRAL RETINA ARTERY OCCLUSION; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FRACTURE; FUNCTIONAL STATUS ASSESSMENT; HUMAN; HYPONATREMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SEIZURE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SUICIDE ATTEMPT; SWEDEN; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; UPPER GASTROINTESTINAL BLEEDING; ADULT; CLINICAL TRIAL; CONVALESCENCE; DRUG ADMINISTRATION; FOLLOW UP; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; SEROTONIN UPTAKE INHIBITORS; STROKE; TREATMENT OUTCOME;

EID: 85088042283     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(20)30219-2     Document Type: Article

References (28)

1. Johnson, CO, Nguyen, M, Roth, GA, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18 (2019), 439–458.
2. Vos, T, Allen, C, Arora, M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1545–1602.
3. McCann, SK, Irvine, C, Mead, GE, et al. Efficacy of antidepressants in animal models of ischemic stroke: a systematic review and meta-analysis. Stroke 45 (2014), 3055–3063.
4. Chollet, F, Tardy, J, Albucher, J-F, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10 (2011), 123–130.
5. Mead, GE, Hsieh, C-F, Lee, R, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev, 11, 2012, CD009286.
6. Mead, G, Hackett, ML, Lundström, E, Murray, V, Hankey, GJ, Dennis, M, The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials. Trials, 16, 2015, 369.
7. Graham, C, Lewis, S, Forbes, J, et al. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis. Trials, 18, 2017, 627.
8. Dennis, M, Mead, G, Forbes, J, et al. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet 393 (2019), 265–274.
9. Affinity Trial Collaboration. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 19 (2020), 651–660.
10. Lundström, E, Isaksson, E, Näsman, P, et al. Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden. Trials, 21, 2020, 233.
11. Counsell, C, Dennis, M, McDowall, M, Warlow, C, Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke 33 (2002), 1041–1047.
12. Brott, T, Adams, HP Jr, Olinger, CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20 (1989), 864–870.
13. Altman, DG, Bland, JM, Treatment allocation by minimisation. BMJ, 330, 2005, 843.
14. Bruno, A, Akinwuntan, AE, Lin, C, et al. Simplified modified Rankin scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke 42 (2011), 2276–2279.
15. Dennis, M, Mead, G, Doubal, F, Graham, C, Determining the modified Rankin score after stroke by postal and telephone questionnaires. Stroke 43 (2012), 851–853.
16. Duncan, PW, Reker, DM, Horner, RD, et al. Performance of a mail-administered version of a stroke-specific outcome measure, the Stroke Impact Scale. Clin Rehabil 16 (2002), 493–505.
17. Duncan, P, Reker, D, Kwon, S, et al. Measuring stroke impact with the stroke impact scale: telephone versus mail administration in veterans with stroke. Med Care 43 (2005), 507–515.
18. Nasreddine, ZS, Phillips, NA, Bédirian, V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53 (2005), 695–699.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders IV. 4th edn., 1994, American Psychiatric Association, Washington, DC.
20. Montgomery, SA, Åsberg, M, A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979), 382–389.
21. van Swieten, JC, Koudstaal, PJ, Visser, MC, Schouten, HJ, van Gijn, J, Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19 (1988), 604–607.
22. Bath, PM, Gray, LJ, Collier, T, Pocock, S, Carpenter, J, Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke 38 (2007), 1911–1915.
23. Riksstroke. Demography of stroke patients in Sweden (in Swedish). Riksstroke. http://www.riksstroke.org/wp-content/uploads/2019/09/Riksstroke_A%CC%8Arsrapport-2018_slutversionWEB.pdf. (Accessed 3 January 2020)
24. Legg, LA, Tilney, R, Hsieh, C-F, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev, 11, 2019, CD009286.
25. Wadhwa, R, Kumar, M, Talegaonkar, S, Vohora, D, Serotonin reuptake inhibitors and bone health: a review of clinical studies and plausible mechanisms. Osteoporos Sarcopenia 3 (2017), 75–81.
26. Rizzoli, R, Cooper, C, Reginster, J-Y, et al. Antidepressant medications and osteoporosis. Bone 51 (2012), 606–613.
27. Tsivgoulis, G, Katsanos, AH, Caso, V, Under-representation of women in stroke randomized controlled trials: inadvertent selection bias leading to suboptimal conclusions. Ther Adv Neurol Disord 10 (2017), 241–244.
28. Chen, X, Li, J, Anderson, CS, et al. Validation of the simplified modified Rankin scale for stroke trials: experience from the ENCHANTED alteplase-dose arm. Int J Stroke, 2020 published online Jan 22. DOI:10.1177/1747493019897858.